Search - tctmd.com

Displaying 21 - 33 of 33

Sort: Relevancy | Date

Presentation THT 2023

CardiacSuccess / V-Sling

Presenter: Horst Sievert

March 21, 2023

Presentation THT 2023

CardiacDimensions

Presenter: Samir Kapadia

March 21, 2023

Presentation THT 2023

Bioventrix

Presenter: Jerry Estep

March 21, 2023

Presentation THT 2023

Ancora

Presenter: Ulrich Jorde

March 21, 2023

Presentation THT 2023

Biological vs Physical Reverse Remodeling: Implications for Device-Based Therapies for HFrEF

Presenter: Michael Brener

March 21, 2023

News Conference News THT 2023

TEER or VAD/Transplant in the Advanced HF Patient With MR?

Shelley Wood

March 20, 2023

Presentation THT 2023

DHF: Who Is Beyond Medical Therapy and in Need of a Device?

Presenter: Ulrich Jorde

March 20, 2023

Presentation THT 2023

When To Transition From Medical to Device-Based Therapy

Presenter: Shelley Hall

March 20, 2023

News Conference News THT 2022

Cardiogenic Shock’s Origins, Progression Tightly Tied to Mortality

Caitlin E. Cox

February 07, 2022

News Conference News THT 2022

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Caitlin E. Cox

February 02, 2022

News Conference News THT 2022

Early Positive Signals From RELIEVE-HF Shift Discussion to Atrial Shunt Size

Shelley Wood

February 02, 2022

Presentation THT 2022

The Need for Device Therapy in HFrEF

Presenter: William Abraham

February 02, 2022

News Conference News THT 2022

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

Shelley Wood

February 01, 2022

Advertisement

CardiacSuccess / V-Sling

CardiacDimensions

Bioventrix

Ancora

Biological vs Physical Reverse Remodeling: Implications for Device-Based Therapies for HFrEF

TEER or VAD/Transplant in the Advanced HF Patient With MR?

DHF: Who Is Beyond Medical Therapy and in Need of a Device?

When To Transition From Medical to Device-Based Therapy

Cardiogenic Shock’s Origins, Progression Tightly Tied to Mortality

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Early Positive Signals From RELIEVE-HF Shift Discussion to Atrial Shunt Size

The Need for Device Therapy in HFrEF

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content